Safety of dupilumab in atopic patients during COVID-19 outbreak.

Safety of dupilumab in atopic patients during COVID-19 outbreak. J Dermatolog Treat. 2020 May 18;:1-5 Authors: Napolitano M, Patruno C, Ruggiero A, Nocerino M, Fabbrocini G PMID: 32419563 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research